Miguel Ángel Morcillo
Miguel Ángel Morcillo is an expert in Oncology at Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (Spain). Miguel Ángel Morcillo has authored 75 publications, the most recent in 2026. SLR score: 175 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Medical Imaging - Pharmacy - Neurology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1987 - 2026
Number : 75
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy. PMID 42394416 — dementia, alzheimer disease, positron-emission tomography, therapeutics, blood platelets, tissues, fibrin | Alzheimers Dement | 2026 | 0 |
| A single-step radiolabeling strategy for PET, SPECT, and therapeutic radionuclides using nanoparticles as a universal chelator. PMID 41667650 — chelating agents, nanoparticles, radiopharmaceuticals, tomography, emission-computed, single-photon, glioblastoma, therapeutics | Npj Imaging | 2026 | 1 |
| Nanoparticle to Nanoparticle Bioorthogonal Detection of Atherosclerosis. PMID 41048110 — antibodies, nanoparticles, nanostructures, atherosclerosis, therapeutics, molecular imaging, plaque, atherosclerotic | ACS Appl Mater Interfaces | 2025 | 0 |
| A Hidden Mark of a Troubled Past: Neuroimaging and Transcriptomic Analyses Reveal Interactive Effects of Maternal Immune Activation and Adolescent THC Exposure Suggestive of Increased Neuropsychiatric Risk. PMID 40115746 — dronabinol, cells, genes, neuroimaging, tomography, positron-emission tomography, brain, biomarkers, adolescent, rna | Biol Psychiatry Glob Open Sci | 2025 | 2 |
| Target engagement of an anti-MT1-MMP antibody for triple-negative breast cancer PET imaging and beta therapy. PMID 38833768 — growth, injections, nuclear medicine, triple negative breast neoplasms, therapeutics, positron-emission tomography, radiobiology, heterografts, matrix metalloproteinases, matrix metalloproteinase 14 | Nucl Med Biol | 2024 | 3 |
LeadR Networks
Main global connection map